Global Top 10 Biotechnology Companies Industry, Financial and SWOT Analysis
Introduction
This report analyzes the global biotechnology market in terms of market size (reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding), key drivers and resistors, trends and competitive positioning. It includes profiles of the top ten companies in the industry along with 5-year financial analysis and in-depth SWOT analysis.
Scope
* Performance of the global biotechnology market on the basis of sales, volume and respective growth patterns over the past five years
* Obtain descriptive profiles of the top ten leading players including strategic initiatives undertaken in the last 12 months
* Analysis of the Strengths, Weaknesses, Opportunities and Threats of the top 10 biotechnology companies along with business overview and financials
* Benchmark the performance of the top 10 players for the past five years; includes revenue comparison, profitability analysis, industry-specific ratios
Highlights
The global biotechnology market grew by 10.6% in 2007 to reach a value of $171,803 million.
In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007.
In value terms, the medical/healthcare segment generated 69.4% of the global biotechnology market value.
Reasons to Purchase
* Save time, money and resources on analyzing the top 10 biotechnology companies using this report
* Analyze the global biotechnology market with key industry metrics including market value, market volume, and growth forecasts
* Assess the intensity of competition based on the 5-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power
This report analyzes the global biotechnology market in terms of market size (reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding), key drivers and resistors, trends and competitive positioning. It includes profiles of the top ten companies in the industry along with 5-year financial analysis and in-depth SWOT analysis.
Scope
* Performance of the global biotechnology market on the basis of sales, volume and respective growth patterns over the past five years
* Obtain descriptive profiles of the top ten leading players including strategic initiatives undertaken in the last 12 months
* Analysis of the Strengths, Weaknesses, Opportunities and Threats of the top 10 biotechnology companies along with business overview and financials
* Benchmark the performance of the top 10 players for the past five years; includes revenue comparison, profitability analysis, industry-specific ratios
Highlights
The global biotechnology market grew by 10.6% in 2007 to reach a value of $171,803 million.
In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007.
In value terms, the medical/healthcare segment generated 69.4% of the global biotechnology market value.
Reasons to Purchase
* Save time, money and resources on analyzing the top 10 biotechnology companies using this report
* Analyze the global biotechnology market with key industry metrics including market value, market volume, and growth forecasts
* Assess the intensity of competition based on the 5-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power
Contents
FiguresTables
Executive Summary
Industry analysis
Industry definition
Research highlights
Top 10 companies landscape
Top 10 companies landscape
Market Value
Market Forecast
Market Segmentation-Product
Market Segmentation-Geographic
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
Top 10 Companies Landscape
Top 10 Companies Landscape
Amgen
Genentech
Gilead Sciences
UCB
Genzyme
Biogen Idec
CSL
Celgene
Cephalon
Actelion
Revenue analysis
Financial performance analysis
Operating profit analysis
Net profit analysis
Ratio analysis
Company Reports
Amgen
Company overview
Business description
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Recent developments
Genentech
Company overview
Business description
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Recent developments
Gilead Sciences
Company overview
Business description
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Recent developments
UCB
Company overview
Business description
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Recent developments
Genzyme
Company overview
Business description
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Recent developments
Biogen Idec
Company overview
Business description
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Recent developments
CSL
Company overview
Business description
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Recent developments
Celgene
Company overview
Business description
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Recent developments
Cephalon
Company overview
Business description
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Recent developments
Actelion
Company overview
Business description
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Recent developments
Financial Analysis
Amgen
Genentech
Gilead Sciences
UCB
Genzyme
Biogen Idec
CSL
Celgene
Cephalon
Actelion
Appendix
LIST OF TABLES
Table 1: Global biotechnology market, $ million, 2003-07
Table 2: Global biotechnology market forecast, $ million, 2007-12
Table 3: Global biotechnology market segmentation-product , % share, 2007
Table 4: Global biotechnology market segmentation-geography, % share, 2007
Table 5: Revenues of global top 10 biotechnology companies, $ million, FY2008
Table 6: Revenue growth of global top 10 biotechnology companies, 2006-08
Table 7: Key financials of global top 10 biotechnology companies, FY2008
Table 8: Key industry specific ratios, FY2008
Table 9: Amgen-Financial and operational highlights, 2004-08 ($ million)
Table 10: Amgen-Key industry specific ratios, 2004-2008
Table 11: Genentech-Financial and operational highlights, 2004-08 ($ million)
Table 12: Genentech-Key industry specific ratios, 2004-08
Table 13: Gilead Sciences-Financial and operational highlights, 2004-08 ($ million)
Table 14: Gilead Sciences-Key industry specific ratios, 2004-08
Table 15: Part(A) UCB-Financial and operational highlights, 2004-08 ($ million)
Table 16: Part(B) UCB-Financial and operational highlights, 2004-08 ($ million)
Table 17: UCB-Key industry specific ratios, 2004-08
Table 18: Genzyme-Financial and operational highlights, 2004-08 ($ million)
Table 19: Genzyme-Key industry specific ratios, 2004-08
Table 20: Biogen Idec-Financial and operational highlights, 2004-08 ($ million)
Table 21: Biogen Idec-Key industry specific ratios, 2004-08
Table 22: CSL-Financial and operational highlights, 2004-08 ($ million)
Table 23: CSL-Key industry specific ratios, 2004-08
Table 24: Celgene- Financial and operational highlights, 2004-08 ($ million)
Table 25: Celgene-Key industry specific ratios, 2004-08
Table 26: Cephalon-Financial and operational highlights, 2004-2008 ($ million)
Table 27: Cephalon-Key industry specific ratios, 2004-08
Table 28: Actelion-Financial and operational highlights, 2004-08 ($ million)
Table 29: Actelion-Key industry specific ratios, 2004-08
LIST OF FIGURES
Figure 1: Global biotechnology market, $ million, 2003-07
Figure 2: Global biotechnology market forecast, $ million, 2007-12
Figure 3: Global biotechnology market segmentation-product, % share, 2007
Figure 4: Global biotechnology market segmentation-geography, % share, 2007
Figure 5: Forces driving competition in the global biotechnology market
Figure 6: Drivers of buyer power in the global biotechnology market
Figure 7: Drivers of supplier power in the global biotechnology market
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology market
Figure 9: Factors influencing the threat of substitutes in the global biotechnology market
Figure 10: Drivers of degree of rivalry in the global biotechnology market
Figure 11: Revenues of global top 10 biotechnology companies, $ million, FY2008
Figure 12: Revenue growth of global top 10 biotechnology companies, 2006-08
Figure 13: Operating performance analysis, FY2008
Figure 14: Net profit analysis, FY2008
Skip to top